While marijuana is currently prohibited in Texas, it is only a matter of time before medical and recreational use is legalized, as the last Viewpoint series produced by the Baker Institute Drug Policy Program argued. When this happens, it will make the cannabis industry open for business in Texas. As we can see from the experiences of states that have legalized recreational and/or medical cannabis, the industry has strong potential for growth. It also faces significant challenges. The future direction for the marijuana industry is important to consider for entrepreneurs, investors, policymakers and the public. In this Baker Institute Viewpoints series, five experts on the marijuana industry examine the question, “What does the future hold for the cannabis industry, in Texas and beyond?”
"The cannabis industry: Growing pains for now, but success will come" by Katharine A. Neill, Ph.D., Alfred C. Glassell III Postdoctoral Fellow in Drug Policy at the Baker Institute.
"The cannabis industry: Challenges in Texas" by Patrick Moran, CEO and managing partner of AquiFlow.
"The cannabis industry: Critical tasks on the road to legalization" by Dr. Elias Jackson, co-founder and president of Vyripharm Biopharmaceuticals.
"The cannabis industry: Enforcing contracts" by Rehman Bhalesha, student at South Texas College of Law.
"The cannabis industry: What does the future hold?" by Leslie Grady McAhren, executive director and director of research at CG Corrigan Inc., a nonprofit, licensed medical provider of cannabis based in Albuquerque, New Mexico.